I still like the co
Almost no debt, growing revenue, generating cash flow, breaking into the US market.
Their approach to writing off R&D costs I believe is prudent even with the P&L volatility created.
If they generate a decent market share in the US this could rocket provided it is not at the cost of the current markets.
I still like the co Almost no debt, growing revenue, generating...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $109.2M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 29.5¢ | $261.4K | 871.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 87168 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 15.33pm 04/07/2025 (20 minute delay) ? |
| AHC (ASX) Chart |